“A Prospective Observational Study of Anthropometric Parameters in Patients with Type 2 Diabetes Mellitus Receiving Dipeptidyl Peptidase-4 Inhibitors: Research Article” (2025) Journal of Pharma Insights and Research, 3(6), pp. 225–230. doi:10.69613/wq9ask44.